Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP

被引:36
|
作者
Bennett, David [1 ]
Salvini, Martina [1 ]
Fui, Annalisa [1 ]
Cillis, Giuseppe [1 ]
Cameli, Paolo [1 ]
Mazzei, Maria Antonietta [2 ]
Fossi, Antonella [1 ]
Refini, Rosa Metella [1 ]
Rottoli, Paola [1 ]
机构
[1] Univ Siena, Dept Med Surg & Neurol Sci, Resp Dis & Lung Transplantat Unit, AOUS, Viale Bracci 16, I-53100 Siena, Italy
[2] Univ Siena, Dept Med Surg & Neurol Sci, Diagnost Imaging Unit, AOUS, Siena, Italy
关键词
biomarkers; bronchoalveolar lavage; calgranulin B; KL-6; idiopathic pulmonary fibrosis; non-specific interstitial pneumonia; PROGNOSTIC VALUE; LUNG; S100A9; FLUID;
D O I
10.1007/s10753-018-00955-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP) are the most frequent idiopathic interstitial pneumonias. The aim of this study was to evaluate concentrations of calgranulin B and Krebs von den Lungen 6 (KL-6) in bronchoalveolar lavage (BAL) fluid of patients with IPF and idiopathic NSIP (i-NSIP) with fibrotic pattern. Thirty patients with IPF (68.73 +/- 8.63years), 30 with i-NSIP (68.33 +/- 7.45years), and healthy controls were included in the study. Calgranulin B and KL-6 both proved to be significantly higher in BAL of IPF and i-NSIP patients than in healthy controls (p<0.05). Calgranulin B showed several significant correlations with functional parameters (oxygen demand at rest, 6-min walking test (6MWT), and PFTs); KL-6 was correlated with oxygen demand at rest and during 6MWT. Patients with higher concentrations of both biomarkers (>75th percentile) had more advanced disease with lower values of FEV1%, FVC%, RV%, TLC%, DLCO% of predicted, distance walked in 6MWT, and BAL neutrophil percentage. Calgranulin B and KL-6 in BAL proved to be reliable biomarkers of IPF and i-NSIP and to have prognostic meaning, discriminating severe and advanced patients. The combination of the two biomarkers can facilitate the stratification of severity.
引用
收藏
页码:463 / 470
页数:8
相关论文
共 50 条
  • [31] Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
    Amal Gad
    Eiji Tanaka
    Akihiro Matsumoto
    Moushira Abd-el Wahab
    Abd el-Hamid Serwah
    Fawzy Attia
    Khalil Ali
    Howayda Hassouba
    Abd el-Raoof el-Deeb
    Tetsuya Ichijyo
    Takeji Umemura
    Hidetomo Muto
    Kaname Yoshizawa
    Kendo Kiyosawa
    [J]. World Journal of Gastroenterology, 2005, (42) : 6607 - 6612
  • [32] Elevation of Serum KL-6 mucin Levels in Patients with Cholangiocarcinoma
    Xu, Huanli
    Inagaki, Yoshinori
    Tang, Wei
    Guo, Qian
    Wang, Fengshan
    Seyama, Yasuji
    Midorikawa, Yutaka
    Gai, Ruoyan
    Kokudo, Norihiro
    Sugawara, Yasuhiko
    Nakata, Munehiro
    Makuuchi, Masatoshi
    [J]. HEPATO-GASTROENTEROLOGY, 2008, 55 (88) : 2000 - 2004
  • [33] Elevated serum KL-6 concentrations in patients with diabetes mellitus
    Takahashi, T
    Takamura, K
    Sakaue, S
    Ishii, J
    Yokouchi, H
    Nasuhara, Y
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2002, 16 (05) : 352 - 358
  • [34] Serial KL-6 measurements in COVID-19 patients
    d'Alessandro, Miriana
    Bergantini, Laura
    Cameli, Paolo
    Curatola, Giuseppe
    Remediani, Lorenzo
    Bennett, David
    Bianchi, Francesco
    Perillo, Felice
    Volterrani, Luca
    Mazzei, Maria Antonietta
    Bargagli, Elena
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (06) : 1541 - 1545
  • [35] KL-6 and poor prognosis in NSCLC patients treated with gefitinib
    Ohara, Gen
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Satoh, Hiroaki
    Hizawa, Nobuyuki
    [J]. LUNG CANCER, 2008, 59 (01) : 138 - 138
  • [36] Circulating KL-6 levels in patients with drug induced pneumonitis
    Ohnishi, H
    Yokoyama, A
    Yasuhara, Y
    Watanabe, A
    Naka, T
    Hamada, H
    Abe, M
    Nishimura, K
    Higaki, J
    Ikezoe, J
    Kohno, N
    [J]. THORAX, 2003, 58 (10) : 872 - 875
  • [37] Serial KL-6 measurements in COVID-19 patients
    Miriana d’Alessandro
    Laura Bergantini
    Paolo Cameli
    Giuseppe Curatola
    Lorenzo Remediani
    David Bennett
    Francesco Bianchi
    Felice Perillo
    Luca Volterrani
    Maria Antonietta Mazzei
    Elena Bargagli
    [J]. Internal and Emergency Medicine, 2021, 16 : 1541 - 1545
  • [38] Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
    Gad, Amal
    Tanaka, Eiji
    Matsumoto, Akihiro
    Abd-el Wahab, Moushira
    Serwah, Abd El-Hamid
    Attia, Fawzy
    Ali, Khalil
    Hassouba, Howayda
    el-Deeb, Abd el-Raoof
    Ichijyo, Tetsuya
    Umemura, Takeji
    Muto, Hidetomo
    Yoshizawa, Kaname
    Kiyosawa, Kendo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (42) : 6607 - 6612
  • [39] SERUM KL-6 LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    OYAMA, T
    DOI, O
    OYAMA, H
    OKUDA, Y
    TAKASUGI, K
    KOHNO, N
    YOKOYAMA, A
    HIRASAWA, Y
    HIWADA, K
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1268 - 1268
  • [40] Galactomannans in bronchoalveolar lavage of patients with Idiopathic Pulmonary Fibrosis (IPF): a possible marker of disease progression
    Cavalli, Francesco
    Puxeddu, Ermanno
    Croce, Giovanni
    Pezzuto, Gabriella
    Rogliani, Paola
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54